Cornercap Investment Counsel Inc Sangamo Therapeutics, Inc Transaction History

Cornercap Investment Counsel Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$1.11 - $1.74 $3,697 - $5,795	3,331 Added 3.83%	90,265 $117,000
Q1 2023 May 11, 2023	BUY	$1.66 - $3.67 $31,579 - $69,818	19,024 Added 28.01%	86,934 $153,000
Q4 2022 Feb 13, 2023	BUY	$2.77 - $5.07 $48,599 - $88,953	17,545 Added 34.84%	67,910 $213,000
Q3 2022 Nov 14, 2022	BUY	$4.27 - $6.39 $67,056 - $100,348	15,704 Added 45.31%	50,365 $247,000
Q2 2022 Aug 15, 2022	BUY	$3.28 - $6.21 $113,688 - $215,244	34,661 New	34,661 $143,000

118

43.8M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $183M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Cornercap Investment Counsel Inc, based on Form 13F filings with the SEC.

Stay updated on Cornercap Investment Counsel Inc with notifications on news.